Trial · NCT01210482
Results by group20
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 20
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Adverse Drug Reactions | TORISEL Injection (Temsirolimus) | ADR | 778 | Participants | |
| Number of Participants With Adverse Drug Reactions | TORISEL Injection (Temsirolimus) | Serious ADR | 352 | Participants | |
| Number of Participants With Adverse Drug Reactions of Major Investigation Items | TORISEL Injection (Temsirolimus) | Mucositis related adverse events | 279 | Participants | |
| Number of Participants With Adverse Drug Reactions of Major Investigation Items | TORISEL Injection (Temsirolimus) | Skin disorder | 209 | Participants | |
| Number of Participants With Adverse Drug Reactions of Major Investigation Items | TORISEL Injection (Temsirolimus) | Interstitial lung disease | 174 | Participants | |
| Number of Participants With Adverse Drug Reactions of Major Investigation Items | TORISEL Injection (Temsirolimus) | Interstitial lung disease suspected events | 3 | Participants | |
| Number of Participants With Adverse Drug Reactions of Major Investigation Items | TORISEL Injection (Temsirolimus) | Infections | 141 | Participants | |
| Number of Participants With Adverse Drug Reactions of Major Investigation Items | TORISEL Injection (Temsirolimus) | Hypercholesterolaemia/hyperlipidaemia | 140 | Participants | |
| Number of Participants With Adverse Drug Reactions of Major Investigation Items | TORISEL Injection (Temsirolimus) | Diabetes/hyperglycaemia | 131 | Participants | |
| Number of Participants With Adverse Drug Reactions of Major Investigation Items | TORISEL Injection (Temsirolimus) | Diarrhoea | 43 | Participants | |
| Number of Participants With Adverse Drug Reactions of Major Investigation Items | TORISEL Injection (Temsirolimus) | Hypophosphataemia | 39 | Participants | |
| Number of Participants With Adverse Drug Reactions of Major Investigation Items | TORISEL Injection (Temsirolimus) | Dyspnea | 35 | Participants | |
| Number of Participants With Adverse Drug Reactions of Major Investigation Items | TORISEL Injection (Temsirolimus) | Acute renal failure | 17 | Participants | |
| Number of Participants With Adverse Drug Reactions of Major Investigation Items | TORISEL Injection (Temsirolimus) | Hypokalaemia | 14 | Participants | |
| Number of Participants With Adverse Drug Reactions of Major Investigation Items | TORISEL Injection (Temsirolimus) | Hypersensitivity reaction | 11 | Participants | |
| Number of Participants With Adverse Drug Reactions of Major Investigation Items | TORISEL Injection (Temsirolimus) | Gastrointestinal perforation | 1 | Participants | |
| Number of Participants With Adverse Drug Reactions of Major Investigation Items | TORISEL Injection (Temsirolimus) | Intracerebral hemorrhage | 1 | Participants | |
| Number of Participants With Adverse Drug Reactions of Major Investigation Items | TORISEL Injection (Temsirolimus) | Wound healing abnormal | 1 | Participants | |
| Overall Response Rate | TORISEL Injection (Temsirolimus) | 6.7 | 95% Confidence Interval 4.9 to 8.9 | Percentage of Participants | |
| Response Rate Excluding Participants Evaluated as Unassessable | TORISEL Injection (Temsirolimus) | 7.4 | Percentage of Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01210482/results